The global AI-enabled X-Ray imaging solutions market is expected to grow from USD 101.6 million in 2021 to USD 569.6 million by 2030, at a CAGR of 20.2% from 2022 to 2030. Artificial intelligence (AI) is currently evolving rapidly, given the availability of huge amounts of data and better machine learning algorithms. From speech recognition to self-driving cars, AI has made its way into daily lives and various industries, including healthcare. AI has become a critical component in the healthcare business, from medication discovery and development to image-guided therapy. Artificial intelligence (AI) algorithms, particularly deep learning, have made significant progress in image recognition tasks. In the field of medical image analysis, methods ranging from convolutional neural networks to variational autoencoders have found a broad array of applications, propelling it forward at a rapid pace.
Rising healthcare costs have aided the integration of AI in healthcare, a lack of communication between physicians and patients, poor health conditions, a shortage of physicians and medical staff, and the rising prevalence of chronic health disorders. As a result, the market's leading manufacturers have created AI-based tools and methodologies for simulating human cognitive activities and analyzing complex medical data in healthcare settings.
In the field of medical imaging, AI-based X-Ray solutions are used for image analysis, detection, diagnosis and decision support, image acquisition, reporting and communication, triage, equipment maintenance, and predictive analysis and risk assessment, among others. The AI algorithms identify patterns in medical images after being trained using many examinations and images, thus detecting abnormalities. Furthermore, deep learning algorithms are used for high-throughput extraction of quantitative data and peculiar features from the images. Likewise, the machine learning algorithms provide valuable information for predicting treatment response and the differentiation of benign and malignant tumors.
Immediately after the outbreak of the COVID-19 pandemic, the focus of the healthcare systems switched to managing the pandemic and related crisis. This led to hospital budgets shrinking and thus resulting in the grim growth of AI.
However, AI is being deployed in radiology departments across the globe to help fight the COVID-19 pandemic. AI-based tools are playing an important role in the pandemic. In China, for instance, an AI model has been deployed at 34 hospitals across the country. The model detects chest CT scans suspicious for COVID-19 patients to be isolated and tested. Similarly, in the U.K, Mexico, and Italy, based on the chest X-Rays pattern and opacities, AI is used to classify low, medium, or high-risk COVID-19 patients. Another algorithm monitors the progression of lung disease on the chest X-Rays of ICU patients. In addition, many AI-based companies are allowing hospitals to use services and technology free of cost or on a trial basis for research that is beneficial to both patients and companies. For instance, Mount Sinai Hospital in New York City is studying the potential of AI to detect COVID-19 by evaluating imaging findings along with the clinical history of patients and demographic characteristics. Thus, research studies suggest that radiologists have played an important role in identifying suspected COVID-19 patients and their disease progression.
With the ongoing advancements in healthcare information technology, the scope of application of AI-enabled medical imaging is rapidly expanding. The use of AI-enabled medical imaging solutions is not limited to cancer screening. It is also becoming widespread in the fields such as neurodiagnostic, coronary diagnostics, and other general medical imaging procedures.
Moreover, algorithms based on AI are currently being used to detect critical bone disorders such as spinal stenosis. They are even used for the diagnosis and prevention of childhood blindness. For instance, the researchers at the Massachusetts General Hospital have introduced an algorithm for automatically labeling the vertebral column and grading spinal stenosis, for which MRI is the most frequently used diagnostic tool. MRI examinations are costly, have high inter-reader variability, and have lengthy acquisition times. Thus, the integration of AI-enabled solutions can assist the radiologists in improving the reporting consistency and decreasing the inter-reader variability.
By deciphering medical device images, expediting medical research, and suggesting diagnoses, AI in healthcare focuses on evaluating patient data to enhance results. A considerable amount of health data is required to train a specific algorithm or AI model. Yet, strict privacy and security concerns constitute a substantial barrier to using this data in developing AI models.
Under federal law, patient data is heavily safeguarded, and any failure or breach in maintaining its integrity could result in legal and financial penalties. The majority of countries have enacted strong privacy laws and regulations that must be obeyed to obtain patient information. For example, the Health Insurance Portability and Accountability Act (HIPAA) is a policy in the U.S. that ensures patient privacy while still requiring the patient's agreement to disclose information.
Deep learning is a subtype of machine learning in AI that mimics the human brain and processes data while also establishing decision-making patterns. In the early 2000s, the discovery of artificial neural networks (ANNs) led to deep learning technologies. With multilayers of neurons, ANNs are evolving and getting more powerful, sophisticated, and deeper, allowing deep learning to assist strong machine learning.
Deep learning is a subtype of machine learning in AI that mimics the human brain and processes data while also establishing decision-making patterns. In the early 2000s, the discovery of artificial neural networks (ANNs) led to deep learning technologies. With multilayers of neurons, ANNs are evolving and getting more powerful, sophisticated, and deeper, allowing deep learning to assist strong machine learning.
The study categorizes the AI-enabled X-Ray imaging solutions market based on product, workflow, mode of deployment, and therapeutic application at the regional and global levels.
The market has been broadly segmented based on the type of products, including hardware and software. Software is the dominating contributor in the market, with a market share of 75.8% in 2021. The software segment includes the machine learning and deep learning solutions used in medical imaging. After being trained by using numerous examinations and images, the AI software solutions are used for various applications, including identification of image patterns and anatomical markers, improvement of radiology workflow, image analysis and acquisition, decision support, treatment selection, and monitoring, predictive analysis, and reporting and communication, among others.
Presently, the market is witnessing an exponential increase in the number of investments and funding to develop AI-based solutions for use in medical imaging. Due to AI technology's promising potential, numerous investors are providing funds to the software manufacturers, which is, in turn, fuelling the market growth. Additionally, the expected emergence of several other companies with AI-based medical imaging solutions under late stages of development is also expected to propel the market growth.
Asia Pacific accounts for the highest CAGR during the forecast period
Based on the regions, the global AI-enabled X-Ray imaging solutions market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. The Asia-Pacific region is expected to witness the highest CAGR of 22.9% during the forecast period 2022-2030. Most of the countries in the Asia-Pacific region are emerging economies facing significant technological advancements and improvements in healthcare systems.
Moreover, since the region comprises more than half of the world’s population, there is an increased healthcare burden, making proper disease diagnosis necessary. However, there is a lack of proper diagnosis in the region attributed to the lack of proper infrastructure and the poor radiologist-to-patient ratio. For instance, despite being a populous country, India has approximately one radiologist for every 100,000 population. Similar is the case with China and other Asian countries. Thus, the integration of AI in radiology practice is a crucial requirement. The manufacturers, along with the government and non-government organizations, are promoting AI in medical imaging.
Every company follows its business strategy to attain the maximum market share. Currently, Agfa-Gevaert NV, Behold.AI Technologies Limited, Carestream Health, Inc., Arterys, Inc., Enlitic, Inc., General Electric Company, Infervision Medical Technology Co. Ltd., Konica Minolta, Inc., Lunit, Inc., Imagen Technologies, Inc., Quibim S.L., Siemens Healthineers AG, Vuno Co. Ltd., Qure.AI Technologies Pvt. Ltd., and Zebra Medical Vision, Inc. are some of the leading players operating in the global AI-enabled X-Ray imaging solutions market.
Frequently Asked Questions
Want to Review Complete Market Research Report
Budget constraints? Get in touch with us for special pricing
Request for Special PricingCustomize this Report
Related Reports
Digital Pathology Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 2024Dry Dental Vacuum Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 20243D Printed Nose Protection Masks Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 2024Disposable Tissue Closure Clamp Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 2024Light Cure Orthodontic Adhesive Market 2024: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Oct 2024